
Bioorganic and Medicinal Chemistry Letters p. 2241 - 2246 (1998)
Update date:2022-08-05
Topics:
Sakaki, Junichi
Murata, Toshiki
Yuumoto, Yoko
Nakamura, Ikushi
Frueh, Thomas
Pitterna, Thomas
Iwasaki, Genji
Oda, Kyoko
Yamamura, Takaki
Hayakawa, Kenji
IRL 3461, N-butanesulfonyl-[N-(3,5-dimethylbenzoyl)-N-methyl-3-[4-(5- isoxazolyl)-phenyl]-alanyl]-(L)-valineamide, a potent and bifunctional (ET(A) + ET(B)) [Ki(ET(A))=1.8 nM, Ki(ET(B))=1.2 nM] antagonist was discovered by structural modification of IRL 2500, an ET(B) selective antagonist. IRL 3461 was found to be stable on incubation with human, rat, mouse, and guinea pig plasmas.
View MoreJiangsu Chiatai Qingjiang Pharmaceutical Co.,Ltd
Contact:+86-517-86283327
Address:9 North Hantai Road, Huaian, China
Tianjin Ingenochem Technology Co.,Ltd
Contact:+86-22-23677060
Address:Hitech Green Industry Park K2-9-602, Nankai district
Qingzhou Baibang import and export co.,Ltd
Contact:+86-536-3265899
Address:No.338, Tuoshan Road
Contact:+86-158-05817090
Address:ROOM 9F, FLAT 2, GUODU DEVELOPING BLDG, No.182, ZHAOHUI ROAD
Mollt Biochem Co., Ltd(expird)
Contact:+86-21-38682181
Address:shanghai ,china
Doi:10.1016/S0040-4039(96)02032-1
(1996)Doi:10.1021/jo961168z
(1997)Doi:10.1016/S0040-4020(99)00444-5
(1999)Doi:10.1002/anie.201703174
(2017)Doi:10.1016/j.tet.2016.08.001
(2016)Doi:10.1139/v96-244
(1996)